Form 4: UPEXI CFO Andrew Norstrud Granted 240,000 Shares
Insider Transaction Report
UPEXI's Chief Financial Officer, Andrew Norstrud, was granted 240,000 shares of common stock as part of the company's Equity Incentive Plan.
Summary
- Andrew James Norstrud, Chief Financial Officer and Director of UPEXI, INC. (UPXI), acquired 240,000 shares of common stock.
- The transaction occurred on October 1, 2025, and was a grant (acquisition) with a price of $0 per share.
- These shares were granted pursuant to the Issuer's Equity Incentive Plan.
- The acquired shares will vest quarterly in equal installments over 12 months, commencing on October 1, 2026.
- Following this transaction, Andrew Norstrud beneficially owns a total of 649,138 shares of common stock.
Sentiment
Score: 7
Explanation: The grant of equity to a key executive is generally a positive event, as it aligns management's interests with shareholders and is a standard practice for executive compensation and retention. No negative implications are apparent from this filing.
Positives
- The equity grant aligns the interests of the Chief Financial Officer and Director, Andrew Norstrud, with those of the shareholders, incentivizing long-term performance.
- The use of an Equity Incentive Plan is a standard corporate governance practice to attract, retain, and motivate key personnel.
Future Outlook
The granted shares will vest quarterly over a 12-month period, beginning October 1, 2026, indicating a future commitment and incentive structure for the Chief Financial Officer.
Industry Context
Equity grants to executive officers are a common practice across industries, serving as a key component of executive compensation packages designed to align management's long-term interests with shareholder value creation. This transaction reflects a standard approach to executive incentives.
Comparison to Industry Standards
- The grant of equity to a Chief Financial Officer as part of an Equity Incentive Plan is a widely adopted compensation strategy, comparable to practices at numerous publicly traded companies across various sectors.
- The vesting schedule over 12 months is a typical short-to-medium term incentive structure, similar to those seen in companies like Microsoft, Apple, or Google for certain types of equity awards, though specific terms vary.
Stakeholder Impact
- Shareholders: The grant of shares to a key executive can be viewed positively as it aligns management's incentives with long-term shareholder value. However, it also represents a potential for future dilution as shares vest, though this is typically factored into equity incentive plans.
- Employees: The use of an Equity Incentive Plan signals the company's commitment to performance-based compensation, which can positively influence employee morale and retention, particularly for other participants in similar plans.
Next Steps
- The granted shares will begin vesting quarterly on October 1, 2026, over a 12-month period.
Key Dates
| Date | Description |
|---|---|
| 10/01/2025 | Date of transaction where 240,000 shares of common stock were acquired. |
| 10/01/2026 | Start date for the quarterly vesting of the granted shares over 12 months. |
| 11/21/2025 | Date the Form 4 was signed by the reporting person. |
Keywords
UPEXI, UPXI, Andrew Norstrud, CFO, Director, Equity Grant, Common Stock, Insider Transaction, Form 4, Equity Incentive Plan, Vesting
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.